NCI at AACR 2020

MONDAY, JUNE 22

The American Association for Cancer Research (AACR) Virtual Annual Meeting II starts today. Registration is free for everyone.

Sign up to view presentations on the latest cancer research from NCI. Learn more about NCI's presence at the meeting on our AACR 2020 webpage.

Attend Today’s Sessions Featuring NCI Speakers

NCI’s cancer research experts are participating in sessions throughout AACR Virtual Annual Meeting II. Be sure to check out the full list of conference abstracts for details and additional sessions. All session times are U.S. EDT.

Today’s Oral Presentations:

Carcinogens at Home: Science and Pathways to Prevention

Presentation: Pesticides in the field and in the home: What do we know about cancer risk?

2:08 - 2:28 p.m. │ NCI Presenter: Mary H. Ward

Join Dr. Ward's presentation to learn about the risks of pesticides, particularly in the home environment where people often spend a majority of their time.

Exceptional Responders and Long-Term Survivors

Presentation: Understanding exceptional responders

2:31 – 2:51 p.m. │ NCI Presenter: Alice P. Chen

Exceptional responders are patients who have a unique response to treatments that are not effective for most other patients. Dr. Chen discusses how exploratory trials, like MATCH, are important to further investigate leads from exceptional responders and generate new exceptional responder leads so additional trials can be developed.

Tomorrow: Dr. Sharpless Delivers the NCI Director’s Address

NCI Director, Ned Sharpless, MD, will present the NCI Director’s Address, “Managing the Now, Focused on the Future,” which will include a live Q&A, moderated by AACR’s immediate Past President, Elaine R. Mardis, PhD, FAACR.

During his presentation, Dr. Sharpless will discuss NCI’s efforts to address racial inequality in cancer research, the potential long-term impact of COVID-19 on cancer mortality, and NCI’s response to ensuring commitment to sustaining and accelerating progress in cancer research. He will share several new studies and funding opportunities that are currently available through NCI - including SARS-CoV-2 Serology research, compassionate use trial of tocilizumab, and the NCCAPS study. Finally, Dr. Sharpless will highlight some recent advances that have been made in cancer research.

Join this session June 23, 2020, 12:00 p.m. EDT. │ Add to Your Itinerary

Seeking Funding for Cancer Research?

Support for the best science underpins everything NCI does. NCI supports scientists and research projects through a rigorous grant application and peer review process. There are several active requests for applications, including new emergency funding for a SARS-CoV-2-Serological Sciences research project that closes soon.

Want to learn more about funding and training at NCI and NIH? Join the session, NCI Funding for Research and Training, on June 24 at 1:45 p.m.